Standigm
Standigm is an artificial intelligence company in Seoul, South Korea, founded in 2015. It has raised $44.5M across 1 round, most recently a $44.5M Venture Round in March 2021.
- Headquarters
- Seoul
- Founded
- 2015
- Business Model
- B2B
- Website
- standigm.com
- Total Funding
- $44.5M
- Last Round
- $44.5M Venture RoundMar 2021
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 8 investors for this company. The full record is or through the API.
About
Standigm develops proprietary and collaborative drug-discovery pipelines using an AI platform that combines biology capabilities for identifying novel targets with chemistry capabilities for designing molecules. It also provides AI platform services to partners worldwide and operates commercial discovery projects alongside SaaS and API products intended to accelerate research. Its multidisciplinary team spans chemistry, biology, pharmacology, artificial intelligence, and data structures.
Summary
It has raised $44.5M in total across 1 round, most recently a $44.5M Venture Round in Mar 2021. Investors include SKS PE, InterVest Capital Partners and Kakao Ventures.
Funding History
Mar 2021
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/standigm"><img src="https://indexed.vc/api/badge/company/standigm" alt="Standigm on Indexed.vc" width="260" height="76" /></a>